The results illustrated a gradual and highly significant increase in blood TAC levels and anti-oxidant enzyme activities (S.O.D., GPx, and CAT) in the groups treated with BV in comparison to the reference groups (control and OXT groups). This evidence concerns the gene CAT and bacterial vaginosis.